- IR News
- News Releases
-
- Jun. 29, 2022 (PDF/146KB)Corporate
- (Update on Disclosed Matter) Notice of Establishment of Holding Company in China
-
- Jun. 03, 2022 (PDF/91KB)R&D
- Myovant Sciences and Pfizer Announce FDA Acceptance of Supplemental New Drug Application for MYFEMBREE
-
- May 13, 2022 (PDF/1,158KB)Finances
- Investors Meeting Presentation for FY2021 (Year ended March 31, 2022)
-
- May 13, 2022 (PDF/307KB)Finances
- Supplementary Financial Data (IFRS) for the Year Ended March 31, 2022
-
- Jun. 29, 2022 (PDF/146KB)Corporate
- (Update on Disclosed Matter) Notice of Establishment of Holding Company in China
-
- Jun. 03, 2022 (PDF/91KB)R&D
- Myovant Sciences and Pfizer Announce FDA Acceptance of Supplemental New Drug Application for MYFEMBREE
-
- May 13, 2022 (PDF/1,158KB)Finances
- Investors Meeting Presentation for FY2021 (Year ended March 31, 2022)
-
- May 13, 2022 (PDF/307KB)Finances
- Supplementary Financial Data (IFRS) for the Year Ended March 31, 2022
-
Recommended Information Rankings
